Absorptive, innovative and adaptive capabilities and their impact on project and project portfolio performance

Ahn, 2010, Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firms, Journal of Commercial Biotechnology, 16, 17, 10.1057/jcb.2009.8 Alvesson, 2009 Archer, 1998 Association of Project Management (APM), 2004 Atkinson, 1999, Project management: cost, time and quality, two best guesses and a phenomenon, it's time to accept other success criteria, International Journal of Project Management, 17, 337, 10.1016/S0263-7863(98)00069-6 Bhaskar, 1975 Biedenbach, 2011, The power of combinative capabilities: facilitating the outcome of frequent innovation in pharmaceutical R&D projects, Project Management Journal, 42, 63, 10.1002/pmj.20221 Biedenbach, 2008, The challenge of organizing change in hypercompetitive industries: a literature review, Journal of Change Management, 8, 123, 10.1080/14697010801953967 Blichfeldt, 2008, Project portfolio management — there's more to it than what management enacts, International Journal of Project Management, 26, 357, 10.1016/j.ijproman.2007.06.004 Booth, 2004, Prospects for productivity, Nature Reviews. Drug Discovery, 3, 451, 10.1038/nrd1384 Bourgeois, 1980, Strategy and environment: a conceptual integration, Academy of Management Review, 5, 25, 10.5465/amr.1980.4288844 Chakravarthy, 1982, Adaptation: a promising metaphor for strategic management, Academy of Management Review, 7, 35, 10.5465/amr.1982.4285438 Churchill, 1979, A paradigm for developing better measures of marketing constructs, Journal of Marketing Research, 16, 64, 10.2307/3150876 Cicmil, 2006 Cuatrecasas, 2006, Drug discovery in jeopardy, The Journal of Clinical Investigation, 116, 2837, 10.1172/JCI29999 Cohen, 1990, Absorptive capacity: a new perspective on learning and innovation, Administrative Science Quarterly, 35, 128, 10.2307/2393553 Collins, 2004, Project success — a survey, Journal of Construction Research, 5, 211, 10.1142/S1609945104000152 Cooper, 2006, Fates intertwined, Nature Biotechnology, 24, 252, 10.1038/nbt0306-252 Cooper, 1999, New product portfolio management: practices and performance, Journal of Product Innovation Management, 16, 333, 10.1016/S0737-6782(99)00005-3 Cooper, 2000, New problems, new solutions: making portfolio management more effective, Research Technology Management, 43, 18, 10.1080/08956308.2000.11671338 Cooper, 2001, Portfolio management for new product development: results of an industry practices study, R&D Management, 31, 361, 10.1111/1467-9310.00225 Coombs, 2002, Innovation in pharmaceuticals: perspectives on the co-ordination, combination and creation of capabilities, Technology Analysis and Strategic Management, 14, 261, 10.1080/095373202200002104 D'Aveni, 1994 D'Aveni, 1998, Waking up to the new era of hypercompetition, The Washington Quarterly, 21, 183, 10.1080/01636609809550302 De Carolis, 2003, Competencies and imitability in the pharmaceutical industry: an analysis of their relationship with firm performance, Journal of Management, 29, 27, 10.1177/014920630302900103 Deeds, 1999, Dynamic capabilities and new product development in high technology ventures: an empirical analysis of new biotechnological firms, Journal of Business Venturing, 15, 211, 10.1016/S0883-9026(98)00013-5 Dietrich, 2005, Successful management of strategic intentions through multiple projects — reflections from empirical study, International Journal of Project Management, 23, 386, 10.1016/j.ijproman.2005.03.002 Eisenhardt, 2000, Dynamic capabilities: what are they?, Strategic Management Journal, 21, 1105, 10.1002/1097-0266(200010/11)21:10/11<1105::AID-SMJ133>3.0.CO;2-E Elmquist, 2007, Towards a new logic for front end management: from drug discovery to drug design in pharmaceutical R&D, Creativity and Innovation Management, 16, 106, 10.1111/j.1467-8691.2007.00424.x Garud, 1994, Transformative capacity: continual structuring by intertemporal technology transfer, Strategic Management Journal, 15, 365, 10.1002/smj.4250150504 Gassmann, 2005, Organizing pharmaceutical innovation: from science-based knowledge creators to drug-orientated knowledge brokers, Creativity and Innovation Management, 14, 233, 10.1111/j.1467-8691.2005.00344.x Geraldi, 2008, The balance between order and chaos in multi-project firms: a conceptual model, International Journal of Project Management, 26, 348, 10.1016/j.ijproman.2007.08.013 Grinstein, 2008, The effect of market orientation and its components on innovation consequences: a meta-analysis, Journal of the Academy of Marketing Science, 36, 166, 10.1007/s11747-007-0053-1 Hagedoorn, 2002, External sources of innovative capabilities: the preferences for strategic alliances or mergers and acquisitions, Journal of Management Studies, 39, 167, 10.1111/1467-6486.00287 Hair, 2006 Hoegl, 2001, Teamwork quality and the success of innovative projects: a theoretical concept and empirical evidence, Organization Science, 12, 435, 10.1287/orsc.12.4.435.10635 Hooley, 1992, Generic marketing strategies, International Journal of Research in Marketing, 9, 75, 10.1016/0167-8116(92)90030-O Hopkins, 2007, The myth of the biotech revolution: an assessment of technological, clinical and organizational change, Research Policy, 36, 566, 10.1016/j.respol.2007.02.013 Ingelgård, 2002, Dynamic learning capability and actionable knowledge creation: clinical R&D in a pharmaceutical company, The Learning Organization, 9, 65, 10.1108/09696470210424015 Khilji, 2006, From invention to innovation: toward developing an integrated innovation model for biotech firms, Journal of Product Innovation Management, 23, 528, 10.1111/j.1540-5885.2006.00222.x Khurana, 1997, Integrating the fuzzy front end of new product development, Sloan Management Review, 38, 103 Khurana, 1998, Towards holistic ‘front ends’ in new product development, Journal of Product Innovation Management, 15, 57, 10.1016/S0737-6782(97)00066-0 Killen, 2008, Learning investments and organizational capabilities: case studies on the development of project portfolio management capabilities, International Journal of Managing Projects in Business, 1, 334, 10.1108/17538370810883800 Killen, 2008, Project portfolio management for product innovation, International Journal of Quality & Reliability Management, 25, 24, 10.1108/02656710810843559 Kim, 2002, Focusing the fuzzy front-end in new product development, R&D Management, 32, 269, 10.1111/1467-9310.00259 King, 1998, Template analysis, 118 King, 2004, Using templates in the thematic analysis of text, 256 Koen, 2001, Providing clarity and a common language to the ‘fuzzy front end’, Research Technology Management, 44, 46, 10.1080/08956308.2001.11671418 Krasnikov, 2008, The relative impact of marketing, research-and-development, and operations capabilities on firm performance, Journal of Marketing, 72, 1, 10.1509/jmkg.72.4.1 Lane, 2006, The reification of absorptive capacity: a critical review and rejuvenation of the construct, Academy of Management Review, 31, 833, 10.5465/AMR.2006.22527456 Lane, 2001, Absorptive capacity, learning, and performance in international joint ventures, Strategic Management Journal, 22, 1139, 10.1002/smj.206 Lichtenthaler, 2009, Absorptive capacity, environmental turbulence, and the complementarity of organizational learning processes, Academy of Management Journal, 52, 822, 10.5465/AMJ.2009.43670902 Liebeskind, 1996, Social networks, learning, and flexibility: sourcing scientific knowledge in new biotechnology firms, Organization Science, 7, 428, 10.1287/orsc.7.4.428 Madhok, 2000, The international biotechnology industry: a dynamic capabilities perspective, Journal of International Business Studies, 31, 325, 10.1057/palgrave.jibs.8490909 Martinsuo, 2007, Role of single-project management in achieving portfolio management efficiency, International Journal of Project Management, 25, 56, 10.1016/j.ijproman.2006.04.002 Meskendahl, 2010, The influence of business strategy on project portfolio management and its success — a conceptual framework, International Journal of Project Management, 28, 807, 10.1016/j.ijproman.2010.06.007 Miles, 1978 Müller, 2008, Project portfolio control and portfolio management performance in different contexts, Project Management Journal, 39, 28, 10.1002/pmj.20053 Nelson, 1982, An evolutionary theory of economic change. Extracts reprinted, 82 Nightingale, 2004, The myth of the biotech revolution, Trends in Biotechnology, 22, 564, 10.1016/j.tibtech.2004.09.010 Oltra, 2003, The impact of technical opportunities and innovative capabilities on firms' output innovation, Creativity and Innovation Management, 12, 137, 10.1111/1467-8691.00277 Partington, 2000, Implementing strategy through programmes of projects, Third, 33 Patton, 1990 Paul, 2010, How to improve R&D productivity: the pharmaceutical industry's grand challenge, Nature Reviews. Drug Discovery, 9, 203, 10.1038/nrd3078 Penrose, 1959 Peteraf, 1993, The cornerstones of competitive advantage: a resource-based view, Strategic Management Journal, 14, 179, 10.1002/smj.4250140303 Petit, 2010, Project portfolios in dynamic environments: sources of uncertainty and sensing mechanisms, Project Management Journal, 41, 46, 10.1002/pmj.20201 Richardson, 1972, The organisation of industry, The Economic Journal, 82, 883, 10.2307/2230256 Pinto, 1989, Critical factors in project implementation: a comparison study of construction and R&D projects, Technovation, 9, 49, 10.1016/0166-4972(89)90040-0 Pinto, 1988, Critical success factors across the project life cycle, Project Management Journal, 19, 67 Pinto, 1989, Critical success factors in R&D projects, Research Technology Management, 32, 31, 10.1080/08956308.1989.11670572 Project Management Institute, 2008 Project Management Institute, 2006 Shenhar, 1996, Toward a typological theory of project management, Research Policy, 25, 607, 10.1016/0048-7333(95)00877-2 Shenhar, 2001, Project success: a multidimensional strategic concept, Long Range Planning, 34, 699, 10.1016/S0024-6301(01)00097-8 Shenhar, 2002, Refining the search for project success factors: a multivariate, typological approach, R&D Management, 32, 111, 10.1111/1467-9310.00244 Sher, 2005, The effects of innovative capabilities and R&D clustering on firm performance: the evidence of Taiwan's semiconductor industry, Technovation, 25, 33, 10.1016/S0166-4972(03)00068-3 Sherry, 2005, Conducting and interpreting canonical correlation analysis in personality research: a user-friendly primer, Journal of Personality Assessment, 84, 37, 10.1207/s15327752jpa8401_09 Snow, 1980, Strategy, distinctive competence, and organizational performance, Administrative Science Quarterly, 25, 317, 10.2307/2392457 Söderlund, 2009, The P-form organization and the dynamics of project competence: project epochs in Asea/ABB, 1950–2000, International Journal of Project Management, 27, 101, 10.1016/j.ijproman.2008.10.010 Subramaniam, 2005, The influence of intellectual capital on the types of innovative capabilities, Academy of Management Journal, 48, 450, 10.5465/AMJ.2005.17407911 Teece, 1997, Dynamic capabilities and strategic management, Strategic Management Journal, 18, 509, 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z Tuominen, 2004, How does adaptability drive firm innovativeness?, Journal of Business Research, 57, 495, 10.1016/S0148-2963(02)00316-8 Turner, 2003, On the nature of the project as a temporary organization, International Journal of Project Management, 21, 1, 10.1016/S0263-7863(02)00020-0 Turner, 2006 Wang, 2007, Dynamic capabilities: a review and research agenda, International Journal of Management Review, 9, 31, 10.1111/j.1468-2370.2007.00201.x Wang, 1997, R&D/marketing interface in a firm's capability-building process: evidence from pharmaceutical firms, International Journal of Innovation Management, 1, 23, 10.1142/S1363919697000036 Wikgren, 2005, Critical realism as a philosophy and social theory in information science?, Journal of Documentation, 61, 11, 10.1108/00220410510577989 Yin, 2003 Zahra, 2002, Absorptive capacity: a review, reconceptualisation, and extension, Academy of Management Review, 27, 185, 10.5465/amr.2002.6587995 Zhang, 2001, The fuzzy front end and success of new product development: a causal model, European Journal of Innovation Management, 4, 95, 10.1108/14601060110390602 Zhao, 2009, Enhancing R&D in science-based industry: an optimal stopping model for drug discovery, International Journal of Project Management, 27, 754, 10.1016/j.ijproman.2009.01.003 Zollo, 2002, Deliberate learning and the evolution of dynamic capabilities, Organization Science, 13, 339, 10.1287/orsc.13.3.339.2780